Scienture Holdings, Inc.
PublicBiotech · Commack, NY
Financials
FY2013–FY2025 · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 5 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Jun 30, 2026| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Preferred stockpreferred | 41,064,146 | — | 100.0% | — |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Mayur Doshi66K (0.67%) Sep 2024 → 126K (0.31%) Apr 2026
- Narasimhan Mani1.4M (14.2%) Sep 2024 → 1.1M (2.56%) Apr 2026
- Prashant Patel139K (20.5%) May 2023 → 177K (8.46%) May 2024 → 178K (1.78%) Sep 2024 → 962K (2.34%) Apr 2026
- Donald G. Fell8K (1.2%) May 2023 → 40K (1.9%) May 2024 → 37K (0.37%) Sep 2024 → 327K (0.8%) Apr 2026
- Shankar Hariharan2.4M (23.7%) Sep 2024 → 1.1M (2.56%) Apr 2026
- Suren Ajjarapu210K (10.1%) May 2024 → 211K (2.12%) Sep 2024
- Michael L. Peterson300K (44.1%) May 2023 → 42K (2.02%) May 2024
Principal holders% as the filing states it, Apr 30, 2026
- Shankar Hariharan1,050,000 Common Stock2.58%of
- Narasimhan Mani1,050,000 Common Stock2.58%of
- Prashant Patel961,687 Common Stock2.37%of
- Subbarao Jayanthi199,872 Common Stock—of
- Donald G. Fell326,860 Common Stock—of
- Surendra Ajjarapu94,268 Common Stock—of
- Eric Sherb50,000 Common Stock—of
- Mayur Doshi125,513 Common Stock—of
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
7 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 82 filings on EDGAR- Form 10-QAug 13, 20260001493152-26-037754EDGAR
- Form 10-QMay 15, 20260001493152-26-023862EDGAR
- Form 10-K/AApr 30, 20260001493152-26-020707EDGAR
- Form 10-KMar 30, 20260001493152-26-013475EDGAR
- Form 10-QNov 12, 20250001493152-25-022032EDGAR
- Form 10-QAug 12, 20250001641172-25-023121EDGAR
- Form D/AAug 7, 20250001641172-25-022629EDGAR
- Form DAug 1, 20250001641172-25-021856EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.